Optibrium and ChemAxon Announce Technology Collaboration

news · 6 years ago
Interface between StarDrop and Plexus facilitates seamless access to both software platforms
Cambridge, UK, and Budapest, Hungary, 15th April, 2015 - Optibrium™ and ChemAxon™, developers of software and cheminformatics solutions for drug discovery, today announced the results of a collaboration to integrate ChemAxon’s Plexus™ with Optibrium’s StarDrop™ software suite. The integration of these platforms further enables researchers to develop strategies for efficient, high quality compound library design.
The StarDrop software platform from Optibrium facilitates multi-parameter optimisation, property prediction and data visualisation to guide the design of high quality compounds for drug discovery projects. ChemAxon’s Plexus is a web based collaborative discovery platform which enables scaffold- and reaction-based enumeration of compound libraries. As a result of the collaboration, a seamlessly integrated workflow and user interface is available in StarDrop for the application of Plexus to enumerate compound libraries. These are returned as data sets within StarDrop for detailed analysis, visualisation and selection of compounds with an optimised balance of the properties required for success. Matthew Segall, CEO of Optibrium, will provide an overview of the results of this collaboration at ChemAxon's European User Group Meeting being held in Budapest, Hungary, May 19-20. For further information on Optibrium and StarDrop, please visit www.optibrium.com/stardrop/ or contact [email protected]. For further information on ChemAxon, please visit www.chemaxon.com or contact [email protected]. To find out more about Plexus Suite and its modules, visit the Plexus Suite product page. Download the full press release here